COGT
Price
$5.33
Change
-$0.39 (-6.82%)
Updated
Apr 3 closing price
Capitalization
607.39M
39 days until earnings call
PBYI
Price
$2.79
Change
-$0.13 (-4.45%)
Updated
Apr 4, 10:45 AM (EDT)
Capitalization
144.12M
27 days until earnings call
Ad is loading...

COGT vs PBYI

Header iconCOGT vs PBYI Comparison
Open Charts COGT vs PBYIBanner chart's image
Cogent Biosciences
Price$5.33
Change-$0.39 (-6.82%)
Volume$1.13M
Capitalization607.39M
Puma Biotechnology
Price$2.79
Change-$0.13 (-4.45%)
Volume$100
Capitalization144.12M
COGT vs PBYI Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. PBYI commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and PBYI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (COGT: $5.33 vs. PBYI: $2.92)
Brand notoriety: COGT and PBYI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 87% vs. PBYI: 70%
Market capitalization -- COGT: $607.39M vs. PBYI: $144.12M
COGT [@Biotechnology] is valued at $607.39M. PBYI’s [@Biotechnology] market capitalization is $144.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whilePBYI’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • PBYI’s FA Score: 1 green, 4 red.
According to our system of comparison, PBYI is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while PBYI’s TA Score has 6 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 4 bearish.
  • PBYI’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, PBYI is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а -19.36% price change this week, while PBYI (@Biotechnology) price change was -7.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

COGT is expected to report earnings on May 13, 2025.

PBYI is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($607M) has a higher market cap than PBYI($144M). PBYI YTD gains are higher at: -4.262 vs. COGT (-31.667). PBYI has higher annual earnings (EBITDA): 48.1M vs. COGT (-271.59M). COGT has more cash in the bank: 287M vs. PBYI (101M). COGT has less debt than PBYI: COGT (17.5M) vs PBYI (74.1M). PBYI has higher revenues than COGT: PBYI (230M) vs COGT (0).
COGTPBYICOGT / PBYI
Capitalization607M144M422%
EBITDA-271.59M48.1M-565%
Gain YTD-31.667-4.262743%
P/E RatioN/A4.69-
Revenue0230M-
Total Cash287M101M284%
Total Debt17.5M74.1M24%
FUNDAMENTALS RATINGS
COGT vs PBYI: Fundamental Ratings
COGT
PBYI
OUTLOOK RATING
1..100
5263
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
9924
PRICE GROWTH RATING
1..100
8862
P/E GROWTH RATING
1..100
10096
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBYI's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for COGT (81) in the Miscellaneous industry. This means that PBYI’s stock grew somewhat faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (71) in the Miscellaneous industry is in the same range as PBYI (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to PBYI’s over the last 12 months.

PBYI's SMR Rating (24) in the Biotechnology industry is significantly better than the same rating for COGT (99) in the Miscellaneous industry. This means that PBYI’s stock grew significantly faster than COGT’s over the last 12 months.

PBYI's Price Growth Rating (62) in the Biotechnology industry is in the same range as COGT (88) in the Miscellaneous industry. This means that PBYI’s stock grew similarly to COGT’s over the last 12 months.

PBYI's P/E Growth Rating (96) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that PBYI’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTPBYI
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 24 days ago
84%
Bullish Trend 17 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVALX5.42N/A
N/A
Forester Value N
HFMRX27.36N/A
N/A
Hartford MidCap R3
GSTOX16.88N/A
N/A
Goldman Sachs Small Cap Gr Insghts Inv
MFWLX16.64N/A
N/A
MFS Global Total Return R6
AVANX13.13N/A
N/A
Avantis® International Small Cap Val G

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-6.82%
SPHDF - COGT
63%
Loosely correlated
N/A
ENGN - COGT
47%
Loosely correlated
+1.35%
ARWR - COGT
46%
Loosely correlated
-4.96%
IDYA - COGT
44%
Loosely correlated
-4.77%
ETNB - COGT
44%
Loosely correlated
-4.59%
More